New Studies Confirm Value of Given Imaging's Advanced Esophageal Diagnostics ... - MarketWatch (press release)
Posted by admin / Under Esophageal PH Monitoring
New Studies Confirm Value of Given Imaging's Advanced Esophageal Diagnostics ... MarketWatch (press release) "These new studies confirm the clinical efficacy of PillCam ESO and Bravo pH monitoring in diagnosing, monitoring, and triaging a variety of esophageal disorders," said David Mason, MD, Chief Medical Officer at Given Imaging. |
Published on Monday 21st of May 2012 01:54:00 AM
Given Imaging Announces Strong Presence at Upcoming Digestive Disease Week(R) 2012 - MarketWatch (press release)
Posted by admin / Under Esophageal PH Monitoring
Given Imaging Announces Strong Presence at Upcoming Digestive Disease Week(R) 2012 MarketWatch (press release) "Since 2001, when Given Imaging introduced capsule endoscopy to gastroenterologists, more than one and a half million PillCam capsules have been ingested by patients to help doctors improve the detection and monitoring of GI diseases. |
Published on Monday 21st of May 2012 01:54:00 AM
Given Imaging Announces Results of 2012 Annual Shareholders' Meeting - MarketWatch (press release)
Posted by admin / Under Esophageal PH Monitoring
Given Imaging Announces Results of 2012 Annual Shareholders' Meeting MarketWatch (press release) The company offers a broad product portfolio including PillCam(R) video capsules for the small bowel, esophagus and colon, industry-leading ManoScan(TM) high-resolution manometry and Bravo(R) wireless and Digitrapper(R) pH and impedance products. |
Published on Monday 21st of May 2012 01:54:00 AM
Act of heroism in the wild blue yonder - Atlanta Journal Constitution
Posted by admin / Under Esophageal PH Monitoring
 Atlanta Journal Constitution | Act of heroism in the wild blue yonder Atlanta Journal Constitution “Blake immediately went forward to provide assistance,” said Genie Dorman, Ph.D., APRN, BC, FNP, a professor at Kennesaw State. “He quickly assessed the man, who was unresponsive and vomiting blood.” “His vital signs were critically low and he was in ... |
Published on Monday 21st of May 2012 01:54:00 AM
Covidien's CEO Discusses Q2 2012 Results - Earnings Call Transcript - Seeking Alpha
Posted by admin / Under Esophageal PH Monitoring
Covidien's CEO Discusses Q2 2012 Results - Earnings Call Transcript Seeking Alpha Also, of note during the quarter, we closed the acquisition of BÂRRX Medical, a market leader in treatment of Barrett's esophagus syndrome. This acquisition broadens our position as the global leader in RF ablation technology, although as Cole said, ... |
Published on Monday 21st of May 2012 01:54:00 AM
Share this!